Cargando…
Possible hypoglycemic action of SX-fraction targeting insulin signal transduction pathway
BACKGROUND: SX-fraction (SXF) is a bioactive glycoprotein with hypoglycemic activity that has been demonstrated in our pilot clinical study. However, how it would actually work in diabetic patients remains unclear. To explore such a mechanism, the effects of SXF on the insulin signal transduction pa...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615842/ https://www.ncbi.nlm.nih.gov/pubmed/23569395 http://dx.doi.org/10.2147/IJGM.S41891 |